Russian HIV Clinical Series Dinara Nabiullina 3rd Edition - 1st Presentation

Russian HIV Clinical Series 2021

Russian HIV Clinical Series Natella Rakhmanina 3rd Edition

Russian HIV Clinical Series 2021

Future Challenges of HIV treatment | Stefano Vella, MD

Global HIV Clinical Forum 2016

Pharmacological Considerations & Clinical Case Discussion | Anna Maria Geretti, MD, PhD, FRCPath

Global HIV Clinical Forum 2016

HIV Therapy in Populations with Unique Challenges – Pediatrics

Global HIV Clinical Forum 2016

Only the Best in Botswana - Optimizing the ART Response | Ava Avalos, MD

Global HIV Clinical Forum 2016

Optimizing HIV Therapy in Resource Limited Settings | François Venter, MD, FCP, PhD

Global HIV Clinical Forum 2016

Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors | Anton Pozniak, MD, FRCP

Global HIV Clinical Forum 2016

Clinical Case Discussion 1 | Pedro Cahn, MD, PhD

Global HIV Clinical Forum 2016

Resistance Characteristics of Integrase inhibitors | Charles Boucher, MD, PhD

Global HIV Clinical Forum 2016

Basic Science of Integrase Inhibitors | Mark Wainberg, MD

Global HIV Clinical Forum 2016

Clinical Case Presentations - Experience with Induction-Maintenance Therapy in real life settings | José Arribas, MD

European HIV Clinical Forum 2016

Induction-Maintenance ARV Therapy: Why, Who, When and How? | Pedro Cahn, MD, PhD

European HIV Clinical Forum 2016

Clinical Utility of Integrase Inhibitors during pregnancy | Saye Khoo, MD, PhD

European HIV Clinical Forum 2016

Clinical Case Presentations – How to manage drug - drug interactions - the practice | Anna Maria Geretti, MD, PhD, FRCPath

European HIV Clinical Forum 2016

How to manage drug - drug interactions - the theory | Giovanni Di Perri, MD, PhD

European HIV Clinical Forum 2016

Impact on: Pharmacology – penetration to sanctuary sites and drug-drug interactions | Courtney Fletcher, PharmD

European HIV Clinical Forum 2016

Impact on: Virology/Resistance | Daniel Kuritzkes, MD

European HIV Clinical Forum 2016

Impact on: Adherence/tolerability | Ian McGowan, MB, ChB, DPhil, MD, FRCP

European HIV Clinical Forum 2016

What is an acceptable BMI | Lee Kaplan, MD, PhD

Symposium on Key Issues in Liver Transplantation for NASH 2016

Role of Bariatric Surgery - Pre-, During or Post-Transplant | Julie Heimbachx, MD

Symposium on Key Issues in Liver Transplantation for NASH 2016

Optimizing Immunosuppression | Mohammed Siddiqui

Symposium on Key Issues in Liver Transplantation for NASH 2016

Panel Discussion

Symposium on Key Issues in Liver Transplantation for NASH 2016

COVID-19: host-factoren, immuniteit en vaccinatie | Anke Bruns, MD, PhD

Post CROI Symposium 2021